Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Yeh

Showing results (31-40 of 274) with videos related to

Pageof 28
Sort By:
Advances in Therapy|March 12, 2011
Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosisE Ann Yeh, B Weinstock-Guttman
The Lancet. Neurology|January 20, 2010
Multiple sclerosis: predicting risk and delaying progressionE Ann Yeh, Bianca Weinstock-Guttman
Neurology|February 13, 2020
Tracking therapies in MS: More evidence in favor of neurofilamentE Ann Yeh, Maria Pia Sormani
Current Neurology and Neuroscience Reports|October 4, 2023
Pediatric Multiple Sclerosis: Changing the Trajectory of ProgressionDaniela Castillo Villagrán, E Ann Yeh
Neurology|September 3, 2021
Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple SclerosisE Ann Yeh, Dennis Bourdette, Heinz Wiendl
Annual Review of Pathology|October 12, 2021
Infection-Related MyelopathiesE Ann Yeh, Carmen Yea, Ari Bitnun
Journal of Child Neurology|September 24, 2014
Outcomes after early administration of plasma exchange in pediatric central nervous system inflammatory demyelinationSandra Bigi, Brenda Banwell, E Ann Yeh
Neurology|December 23, 2018
Forecasting outcomes in anti-NMDAR encephalitis: Clearer prognostic markers neededStephan Rüegg, E Ann Yeh, Jerome Honnorat
Seminars in Neurology|December 29, 2025
Federated Learning in Neurology: Bridging Data Privacy and Artificial Intelligence for Brain HealthSahar Soltanieh, Farzad Khalvati, E Ann Yeh
Neurology. Clinical Practice|June 30, 2025
Exploring Treatment Approaches in Pediatric MOG Antibody-Associated Disease: A Survey of NeurologistsRabporn Suntornlohanakul, Carmen Yea, E Ann Yeh
Pageof 28

Showing results (31-40 of 274) with videos related to

Sort By:
Pageof 28
Advances in Therapy|March 12, 2011
Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosisE Ann Yeh, B Weinstock-Guttman
The Lancet. Neurology|January 20, 2010
Multiple sclerosis: predicting risk and delaying progressionE Ann Yeh, Bianca Weinstock-Guttman
Neurology|February 13, 2020
Tracking therapies in MS: More evidence in favor of neurofilamentE Ann Yeh, Maria Pia Sormani
Current Neurology and Neuroscience Reports|October 4, 2023
Pediatric Multiple Sclerosis: Changing the Trajectory of ProgressionDaniela Castillo Villagrán, E Ann Yeh
Neurology|September 3, 2021
Longer-term Safety of B-Cell Therapy With Ocrelizumab in Multiple SclerosisE Ann Yeh, Dennis Bourdette, Heinz Wiendl
Annual Review of Pathology|October 12, 2021
Infection-Related MyelopathiesE Ann Yeh, Carmen Yea, Ari Bitnun
Journal of Child Neurology|September 24, 2014
Outcomes after early administration of plasma exchange in pediatric central nervous system inflammatory demyelinationSandra Bigi, Brenda Banwell, E Ann Yeh
Neurology|December 23, 2018
Forecasting outcomes in anti-NMDAR encephalitis: Clearer prognostic markers neededStephan Rüegg, E Ann Yeh, Jerome Honnorat
Seminars in Neurology|December 29, 2025
Federated Learning in Neurology: Bridging Data Privacy and Artificial Intelligence for Brain HealthSahar Soltanieh, Farzad Khalvati, E Ann Yeh
Neurology. Clinical Practice|June 30, 2025
Exploring Treatment Approaches in Pediatric MOG Antibody-Associated Disease: A Survey of NeurologistsRabporn Suntornlohanakul, Carmen Yea, E Ann Yeh
Pageof 28